Introduction
Endotoxins are lipopolysaccharides (LPS) contained in cell walls of Gram-negative bacteria. Bacterial endotoxins have been recognized as a major cause of pyrogenic reactions that could be encountered during the administration of biotherapeutics (Hou and Zaniewski, 1990) . Therefore, the elimination of endotoxins is crucial for the purification of biotherapeutics intended for injection in human. It is known that LPS subunits (monomers) have a molecular weight of approximately 10,000 to 20,000 daltons (EvansStrikfaden and Oshima, 1996) . Normally, these subunits aggregate into vesicles with a molecular weight around 1,000,000 daltons (Pearson, 1985) . The aggregation is believed to be facilitated by cations. Because LPS has negatively charged phosphate groups, cations, especially divalent cations such as Ca ϩ2 and Mg ϩ2 can act as ''bridges'' between LPS subunits (Schindler and Osborn, 1979) , resulting in LPS bilayer sheets or vesicles with a diameter of the order of 0.1m in water (Nelsen, 1978; Pearson, 1985) . It is also known that some proteins can disaggregate endotoxins and form complexes with LPS in biological solutions, which makes the removal of endotoxin from protein-based biopharmaceutical products more complicated. In a previous study, we have investigated the concentration effect of hemoglobin on protein-LPS binding and endotoxin removal (Li and Luo, 1997) .
Some studies have shown that the addition of divalent cations enhanced the LPS aggregation in water (Galanos and Lüderitz, 1975) . However, whether the LPS subunits bound to protein molecules in a biological solution will reaggregate upon adding divalent cations is unknown. In this study, a method of two stage ultrafiltration was used to investigate the effect of Ca ϩ2 on LPS re-aggregation in hemoglobin solutions and the removal of endotoxin. Pure endotoxin in aqueous solutions can not pass through the ultrafiltration membranes rated at 300,000 nominal molecular weight cut-off (NMWCO). If endotoxin aggregates are broken down by protein molecules and form smaller protein-LPS complexes, the complexes will pass the membrane and endotoxin will be found in the filtrate. If LPS subunits in complexes are re-aggregated and form large vesicles again in the solution, then the large vesicles will not pass the membrane and endotoxin will not be found in the filtrate.
Materials and methods

Materials
Endotoxin from Escherichia coli 026:B6 and human hemoglobin A o (HbA o , ferrous) were from Sigma. Hemoglobin and endotoxin solutions were prepared with endotoxin-free 0.15 M NaCl solution. 0.1 M endotoxin-free HCl, 0.1 M endotoxin-free NaOH, NaCl (molecular biology reagent), CaCl 2 ·2H 2 O (molecular biology reagent), endotoxin-free water and endotoxin detection kit E-TOXATE were from Sigma. Ultrafree-CL polysulfone 300,000 NMWCO ultrafiltration membrane filters were from Millipore. All glassware used was autoclaved in an autoclave (Series 300, Harvard/LTE) for 1 hr and followed with heating in an oven (Thelco Model 16, Precision Scientific Co.) at 175 °C for 3 hrs. All solution transfers were performed by endotoxin-free devices.
Endotoxin detection
Endotoxin was detected using Limulus amebocyte lysate (LAL) test. Gelation was taken as the endpoint. Endotoxin from Escherichia coli 055:B5 was used as the standard. For standard endotoxin detection, when endotoxin concentration was greater than 0.06 Endotoxin Unit (EU) /ml, solid gel formed and the LAL test gave positive result.
Protein-LPS binding study Seven 0.9 ml hemoglobin A o solutions at various concentrations (Table 1) were put into 1.5 ml sterile Eppendorf microcentrifuge tubes respectively, then 0.1 ml 50.0 g LPS /ml endotoxin solution was added to each tube. The mixtures were incubated in a water bath at 37 °C for 30 minutes. After incubation, the solutions were applied to 300,000 NMWCO polysulfone ultrafiltration membranes and ultrafiltration was performed by centrifuging at 1800 g for 5 minutes. This is the first ultrafiltration, as shown in Figure 1 . 0.1 ml filtrate of each solution was set aside for LAL test, and the remaining filtrate was divided into two parts, one part was used for LPS re-aggregation study with CaCl 2 . Another was used for a control experiment with NaCl.
Endotoxin re-aggregation study Seven 0.2 ml filtrates at various hemoglobin concentrations from the first ultrafiltration were put into 1.5 ml sterile Eppendorf microcentrifuge tubes. Then 0.2 ml of 0.09 M endotoxin-free CaCl 2 solution was added to each tube. The ionic strength of the CaCl 2 solution was 0.27 M. The mixtures were incubated in a water bath at 37 °C for 30 minutes. After incubation, the solutions were applied to 300,000 NMWCO polysulfone ultrafiltration membranes and the ultrafiltration was performed by centrifuging at 1800 g for 5 minutes. This is the second ultrafiltration as shown in Figure 1 . 0.1 ml filtrate of each solution was subjected to LAL test. In order to conduct a control experiment that was used as a comparison to the endotoxin re-aggregation study in CaCl 2 solution, 0.27 M NaCl solution was used to study the aggregation state of LPS in the mixtures. The ionic strength of NaCl solution was 0.27 M, as same as that of CaCl 2 solution. The experiment procedure was similar to that of the endotoxin reaggregation study in CaCl 2 solution.
Results and discussion
Protein-LPS binding study
The LAL test results of protein-LPS binding study are shown in Table 1 . In this study, the hemoglobin A o concentration in the mixture was changed from 144.0 g/ ml to 76.5 g/ml, while the endotoxin concentration was kept the same at 5.0 g LPS /ml in every mixture. Meanwhile the HbA o and LPS concentration ratio was Figure 1 The experimental procedure: protein/ LPS mixtures at various concentration ratios were incubated at 37 °C for 30 minutes. After incubation, the mixtures were applied to the first ultrafiltration. To each filtrate at various protein/LPS ratios from the first ultrafiltration Ca ϩ2 or Na ϩ solution was added respectively. The resulting mixtures were incubated and the second ultrafiltration was conducted.
